Telly Sepahpour, Jalal Alshaweesh, Nazli Azodi, Komudi Singh, Derek D C Ireland, Farzaneh Valanezhad, Risa Nakamura, Abhay R Satoskar, Ranadhir Dey, Shinjiro Hamano, Hira L Nakhasi, Sreenivas Gannavaram
{"title":"Downregulation of IRF7-mediated type-I interferon response by LmCen<sup>-/-</sup> parasites is necessary for protective immunity.","authors":"Telly Sepahpour, Jalal Alshaweesh, Nazli Azodi, Komudi Singh, Derek D C Ireland, Farzaneh Valanezhad, Risa Nakamura, Abhay R Satoskar, Ranadhir Dey, Shinjiro Hamano, Hira L Nakhasi, Sreenivas Gannavaram","doi":"10.1038/s41541-024-01032-6","DOIUrl":null,"url":null,"abstract":"<p><p>Leishmaniasis is a tropical disease caused by Leishmania parasites and currently has no licensed vaccines. We developed a dermotropic Leishmania major centrin gene-deleted strain (LmCen<sup>-/-</sup>) as a live attenuated vaccine. Recent studies have shown that type I interferons (IFNs) play important roles in immunity to parasitic and viral pathogens. However, their relevance in protective immunity following vaccination is not understood. We found that immunization with LmCen<sup>-/-</sup> induces a transient increase in type I IFN response along with its regulatory factor IRF7 that is downregulated 7-21 days post-immunization, coincided with the induction of a robust Th1 adaptive immune response. Challenge infection with virulent L. donovani parasites showed a significant reduction of splenic and hepatic parasite burden in IRF7<sup>-/-</sup> mice than wild type mice following immunization with LmCen<sup>-/-</sup>, suggesting that ablation of type I IFN response is a pre-requisite for the induction of LmCen<sup>-/-</sup> mediated Th1 immunity against L. donovani infection.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"9 1","pages":"250"},"PeriodicalIF":6.9000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659581/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-024-01032-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Leishmaniasis is a tropical disease caused by Leishmania parasites and currently has no licensed vaccines. We developed a dermotropic Leishmania major centrin gene-deleted strain (LmCen-/-) as a live attenuated vaccine. Recent studies have shown that type I interferons (IFNs) play important roles in immunity to parasitic and viral pathogens. However, their relevance in protective immunity following vaccination is not understood. We found that immunization with LmCen-/- induces a transient increase in type I IFN response along with its regulatory factor IRF7 that is downregulated 7-21 days post-immunization, coincided with the induction of a robust Th1 adaptive immune response. Challenge infection with virulent L. donovani parasites showed a significant reduction of splenic and hepatic parasite burden in IRF7-/- mice than wild type mice following immunization with LmCen-/-, suggesting that ablation of type I IFN response is a pre-requisite for the induction of LmCen-/- mediated Th1 immunity against L. donovani infection.
NPJ VaccinesImmunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍:
Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.